drugset / Trial / NCT02209545

Misoprostol for Reduction of Blood Loss During Fibroid Surgery

NCT02209545

Phase 4 Terminated 47 enrolled Northwestern University
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this research work is to assess the impact of a single preoperative dose of buccal misoprostol in reducing blood loss during abdominal fibroid surgery.

Timeline

Start
2014-10
Primary completion
2022-07
Completion
2022-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 400 ug Other

Indications